SERPINA3, a protease inhibitor, was found to be down‐regulated in the failing myocardium from patients with DCM,40 and the up‐regulation of SERPINA3 is associated with poor survival in patients with HF.41 This evidence concerns the gene SERPINA3 and familial dilated cardiomyopathy.